These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2874951)

  • 21. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of serotonin receptors in the rat brain.
    Hamon M; Nelson DL; Herbet A; Bockaert J; Glowinski J
    Monogr Neural Sci; 1980; 7():161-75. PubMed ID: 7231436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of serotonin in rat lung.
    Das DK; Steinberg H
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E58-63. PubMed ID: 3966551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
    Zemlan FP; Schwab EF
    J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artifactual high-affinity and saturable binding of [3H]5-hydroxytryptamine induced by radioligand oxidation.
    Peroutka SJ; Ison PJ; Liu DU; Barrett RW
    J Neurochem; 1986 Jul; 47(1):38-45. PubMed ID: 3711910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I; Combs MR; Jones DJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
    Nelson DL; Monroe PJ; Lambert G; Yamamura HI
    Life Sci; 1987 Sep; 41(13):1567-76. PubMed ID: 2957559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
    Heuring RE; Peroutka SJ
    J Neurosci; 1987 Mar; 7(3):894-903. PubMed ID: 2951504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain.
    Castro ME; Romón T; Castillo MJ; del Olmo E; Pazos A; del Arco C
    J Neurochem; 1997 Nov; 69(5):2123-31. PubMed ID: 9349558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum.
    Yoshikawa T; Yoshida N; Mine Y; Hosoki K
    Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW; Shih JC
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of [3H]-5-hydroxytryptamine to homogenates of human brain.
    Dehlin E; Marcusson J; Fowler CJ; Winblad B
    J Neural Transm; 1982; 54(1-2):91-103. PubMed ID: 7108513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D; Neijt HC
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence on 5-[3H]hydroxytryptamine binding site development in chick embryo by serotonergic compounds.
    Soblosky JS; Jeng I
    J Neurochem; 1985 Feb; 44(2):544-51. PubMed ID: 2578180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the binding of 3H-norzimeldine, a 5-HT uptake inhibitor, to rat brain homogenates.
    Hall H
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):33-40. PubMed ID: 6235721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes.
    VandenBerg SR; Allgren RL; Todd RD; Ciaranello RD
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3508-12. PubMed ID: 6574495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
    Gobbi M; Parotti L; Mennini T
    Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of [3H]paroxetine binding to rat cortical membranes.
    Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
    Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.